Nathan H. Fowler, MD, discusses the latest addition to the treatment landscape for marginal zone lymphoma.
Nathan H. Fowler, MD
Advertisement
Articles by Nathan H. Fowler, MD
Advertisement
Latest Updated Articles
Emerging Targeted Therapies in Marginal Zone LymphomaPublished: April 10th 2019 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
